Legend Biotech (LEGN) Change in Account Payables (2020 - 2026)

Legend Biotech (LEGN) has 7 years of Change in Account Payables data on file, last reported at -$8.1 million in Q1 2026.

• Quarterly Change in Account Payables fell 141.54% year-over-year to -$8.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $52.2 million (up 384.97% YoY) and the FY2024 annual result came in at $14.1 million, up 128.01% from the prior year.
• Change in Account Payables eased to -$8.1 million in Q1 2026, from $24.3 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $41.9 million in Q4 2022 to a low of -$34.5 million in Q4 2023.
• A 5-year average of $5.5 million and a median of $2.6 million in 2022 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2022 — Change in Account Payables jumped 4178.72% — and 2023, when it sank 430.02%.
• Tracing LEGN's Change in Account Payables over 5 years: stood at $41.9 million in 2022, then tumbled by 182.21% to -$34.5 million in 2023, then jumped by 117.51% to $6.0 million in 2024, then surged by 302.04% to $24.3 million in 2025, then plunged by 133.38% to -$8.1 million in 2026.
• The last three Change in Account Payables figures came in at -$8.1 million (Q1 2026), $24.3 million (Q3 2025), and $16.5 million (Q2 2025), per Business Quant data.